Sinocare Medical: Approval obtained for registration application of sirolimus drug-coated coronary balloon dilatation catheter.
Sinocare Medical announced that the registration application of the company's sirolimus drug-coated coronary balloon dilation catheter ACOART CANNA was approved by the China National Medical Products Administration on July 31, 2025. This product is used for the dilation treatment of primary coronary artery bifurcation lesions with a vessel diameter 2.0mm and 4.0mm. Clinical trial results show that the rate of stenosis of the target lesion branch vessel diameter at 9 months post-surgery was 30.52%, with no statistical difference compared to the control group's 33.46%, and no abnormal risks or events were observed.
Latest